Observational studyAnnals of clinical and translational neurology2021

Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population.

Eva Fernandez-Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.